📋 Monitoring Program Activities: Ensuring Quality at Every Step

To deliver high-quality DR-TB care, we conduct regular monitoring and evaluation across all treatment sites. This helps us ensure data accuracy, compliance with guidelines, and continual improvement of services.

Monitoring and evaluation (M&E) are critical in public health programs, especially when dealing with complex diseases like Drug-Resistant Tuberculosis (DR-TB). It helps ensure that:

• The care provided is effective and safe
• The data collected is reliable for decision-making
• The program adapts quickly to changing needs or treatment guidelines
• Stakeholders, funders, and the government can track accountability and performance

📌 Main Highlights

📂 Digital Patient Records

• Every DR-TB patient has a digital profile.
• These records store patient registration details, diagnostic results, treatment regimens, and follow-up progress.
• It reduces paperwork, prevents loss of data, and ensures continuity of care even when staff changes.

🔐 Secure, Real-Time Access

• Authorized healthcare providers can access records instantly.
• This enables faster response times when something changes in a patient’s condition.
• It also helps prevent duplication or delays in treatment.

📊 Monitoring Dashboards

• These dashboards give program managers and supervisors a bird’s-eye view of:
  • Number of patients registered
  • Drug stock levels
  • Test results (GeneXpert, culture, DST, etc.)
  • Treatment adherence
  • Site-level performance
• They help identify gaps, such as:
  • Sites not updating data regularly
  • Patients missing follow-ups
  • Delays in lab results

🎯 Impact of Strong Monitoring

With robust monitoring systems:

• Errors or delays in patient care are detected early and corrected.
• Resources are used more efficiently.
• Frontline workers feel more supported, knowing they are backed by real-time systems.
• The program can show evidence of impact to donors and policymakers.